Trailing Dividend / Share
$11.19
Novo Nordisk A/S (NVO) Dividend History
Income profile from 1985 to 2026 with payout safety and yield-on-cost trend
Dividend Yield
4.7%
Payout Ratio
50.5%
Sustainable
Dividend Streak
8 years
3-Second Income Check
Safety
50.5% payout ratio with sustainable safety profile.
Consistency
8 straight years of dividend increases.
Income Trend
Yield on cost is 3.4% and trend is rising.
Dividend Scorecard
Yield & Income
Dividend Yield4.7%
Trailing DPS$11.19
FrequencyAnnual
Payments / 12M3
Payout Safety
Earnings Payout50.5%
Earnings SafetySustainable
FCF Payout88.6%
FCF SafetyStretched
Piotroski F-Score5/9
Growth
Growth Streak8 years
3Y CAGR15.4%
5Y CAGR13.6%
Yield on Cost (5Y)3.4%
YOC Trendrising
Total Returns
Buyback Yield0.2%
Total Shareholder Yield4.9%
1Y Total Return-57.3%
5Y Total Return16.1%
Div Contribution (5Y)13.2%
Estimated $10K growth (return + dividends):
5Y ago$11,60710Y ago$17,68320Y ago$161,311
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Income Growth Story
Dividend per share and yield on cost over time (42 years of payments)
Dividend Safety Story
EPS is the container — dividend is what's drawn out
Dividend Analysis
Payout Safety
Novo Nordisk A/S distributes 50.5% of earnings as dividends (Sustainable). When measured against free cash flow—a stricter test—the payout ratio stands at 88.6%, rated "Stretched".
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
NVO has raised its dividend for 8 consecutive years, with a 3-year CAGR of 15.4% and 5-year CAGR of 13.6%.
Total Shareholder Returns
Beyond cash dividends, NVO returns capital through share repurchases. The combined picture: 4.7% dividend yield, 0.2% buyback yield, 4.9% total shareholder yield.
Income Trend & Total Return
Yield on cost (5-year basis) has reached 3.4% and is currently rising. The 5-year total return is 16.1%, with dividends contributing 13.2% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $17,683 today.
FCF payout is stretched — the dividend consumes a large share of free cash flow.
Recent Dividend Payments
Last 20 payments · Annual
TTM Total$8.43
Avg/Payment$0.4217
Latest Change+122.5%
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| Mar 30, 2026Latest | $0.9158 | ↑ +122.5% | 3.54% | Apr 8, 2026 |
| Aug 18, 2025 | $0.4116 | ↓ -49.8% | 2.29% | Aug 26, 2025 |
| Mar 31, 2025 | $0.8191 | ↑ +126.1% | 1.70% | Apr 8, 2025 |
| Aug 16, 2024 | $0.3623 | ↓ -45.4% | 76.04% | Aug 26, 2024 |
| Mar 22, 2024 | $0.6634 | ↑ +51.4% | 85.55% | Apr 2, 2024 |
| Aug 18, 2023 | $0.4382 | ↓ -25.8% | 1.12% | Aug 29, 2023 |
| Mar 24, 2023 | $0.5903 | ↑ +104.3% | 1.15% | Apr 4, 2023 |
| Aug 12, 2022 | $0.2889 | ↓ -43.5% | 1.49% | Aug 23, 2022 |
Dividend Peer Comparison
Peer group: Specialty and biologics-focused pharma
#1 yield in peer group
Div Yield
4.7%
#1 of 3
Safety
Sustainable
50.5% payout
Streak
8Y
13.6% 5Y CAGR
Total Shareholder
4.9%
#1 of 3
Annual Dividend History
42 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2026YTD | $0.92 | — | 1 | — | — | — | 2.6% |
| 2025 | $1.23 | 20.0% | 2 | $23.03 | 5.3% | 18.71x | 3.4% |
| 2024 | $1.03 | -0.3% | 2 | $22.63 | 4.5% | 22.06x | 2.9% |
| 2023 | $1.03 | 28.5% | 2 | $18.62 | 5.5% | 18.10x | 2.9% |
| 2022 | $0.80 | 8.7% | 2 | $12.22 | 6.5% | 15.27x | 2.2% |
| 2021 | $0.74 | 13.2% | 2 | $10.37 | 7.1% | 14.09x | 2.1% |
| 2020 | $0.65 | 6.0% | 2 | $9.01 | 7.2% | 13.86x | 1.8% |
| 2019 | $0.61 | -3.3% | 2 | $8.19 | 7.5% | 13.36x | 1.7% |
| 2018 | $0.63 | 10.8% | 2 | $7.97 | 8.0% | 12.57x | 1.8% |
| 2017 | $0.57 | -18.9% | 2 | $7.70 | 7.4% | 13.46x | 1.6% |
See NVO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVO Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NVO vs AGIO
See how NVO stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does NVO pay per share?
Novo Nordisk A/S (NVO) pays a trailing 12-month dividend of $11.19 per share, with a current dividend yield of +4.7%. Payments are made Annual.
When is NVO's next ex-dividend date?
NVO's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. NVO typically pays dividends Annual.
Is NVO's dividend safe?
NVO's dividend safety is rated "Sustainable" based on an earnings payout ratio of +50.5% and FCF payout ratio of +88.6%. The 8-year growth streak provides moderate confidence.
Is NVO a Dividend Payer?
Yes, Novo Nordisk A/S is classified as a Dividend Payer with 8 consecutive years of dividend increases. The 5-year dividend CAGR is +13.6%, demonstrating above-inflation dividend growth.
How often does NVO pay dividends?
Novo Nordisk A/S pays dividends Annual. The trailing 12-month total is $11.19 per share. Dividend data on this page covers 41+ years from 1985 to 2026.
How much would $10,000 invested in NVO grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in NVO five years ago would be worth approximately $11,607 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is NVO's yield on cost for long-term holders?
NVO's yield on cost — the current dividend divided by the original purchase price — is +3.4% for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +4.7% market yield, thanks to consistent dividend growth.